DaVita Inc. (DVA) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DVA Revenue Growth
Revenue Breakdown (FY 2025)
DVA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
DVA Revenue Analysis (2014–2025)
As of May 8, 2026, DaVita Inc. (DVA) generated trailing twelve-month (TTM) revenue of $13.84 billion, reflecting solid growth of +6.0% year-over-year. The most recent quarter (Q1 2026) recorded $3.42 billion in revenue, down 5.6% sequentially.
Looking at the longer-term picture, DVA's 5-year compound annual growth rate (CAGR) stands at +3.4%, indicating moderate growth over time. The company achieved its highest annual revenue of $14.75 billion in 2016.
Revenue diversification analysis shows DVA's business is primarily driven by U S Dialysis And Related Lab Services (100%). With over half of revenue concentrated in U S Dialysis And Related Lab Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including FMS (-0.7% YoY), FXNC, and UNH (+9.7% YoY), DVA has underperformed the peer group in terms of revenue growth. Compare DVA vs FMS →
DVA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DVACurrent | $13.8B | +6.0% | +3.4% | 14.7% | |
 FMS | $19.6B | -0.7% | +1.9% | 9.3% | |
 FXNC | $112M | - | - | 19.6% | |
 UNH | $447.6B | +9.7% | +11.7% | 4.2% | |
 HUM | $129.7B | +14.1% | +10.9% | 1.1% | |
 CNC | $194.8B | +17.0% | +11.9% | -3.9% |
DVA Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $13.64B | +6.5% | $3.68B | 27.0% | $2.01B | 14.7% |
| 2024 | $12.82B | +5.6% | $4.22B | 32.9% | $2.09B | 16.3% |
| 2023 | $12.14B | +4.6% | $3.82B | 31.5% | $1.60B | 13.2% |
| 2022 | $11.61B | -0.1% | $3.40B | 29.3% | $1.34B | 11.5% |
| 2021 | $11.62B | +0.6% | $3.65B | 31.4% | $1.80B | 15.5% |
| 2020 | $11.55B | +1.4% | $3.56B | 30.8% | $1.69B | 14.7% |
| 2019 | $11.39B | -0.1% | $3.47B | 30.5% | $1.64B | 14.4% |
| 2018 | $11.40B | +4.9% | $3.21B | 28.1% | $1.53B | 13.4% |
| 2017 | $10.88B | -26.2% | $3.24B | 29.8% | $1.81B | 16.7% |
| 2016 | $14.75B | +7.0% | $3.28B | 22.2% | $2.03B | 13.8% |
Full DVA Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See DVA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DVA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DVA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDVA — Frequently Asked Questions
Quick answers to the most common questions about buying DVA stock.
Is DVA's revenue growth accelerating or slowing?
DVA maintains +6.0% revenue growth, in line with its 5-year CAGR of +3.4%. TTM revenue stands at $13.8B. Growth rate remains consistent with historical average.
What is DVA's long-term revenue growth rate?
DaVita Inc.'s 5-year revenue CAGR of +3.4% reflects the sustained expansion pattern. Current YoY growth of +6.0% is near this long-term average.
How is DVA's revenue distributed by segment?
DVA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.